The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Ovarian serous borderline tumors: A critical review of the literature with emphasis on prognostic indicators
Open accessAbstract
BACKGROUND: The behavior of ovarian serous borderline tumors (SBTs) and significance of various prognostic factors are unclear and difficult to evaluate because of inconsistencies and confusion in the literature. Recent studies have suggested that the morphological features of the primary tumor (presence or absence of micropapillary features) and the peritoneal "implants" (presence or absence of invasive features) can reliably subclassify SBTs into benign and malignant types. The aim of the current review was to test two hypotheses. First, that the alleged malignant behavior of SBTs is poorly documented, and second, that the morphological features of the primary ovarian tumors and the associated peritoneal implants are sufficient to separate SBTs into benign and malignant types, thereby obviating the need for the category. METHODS: 245 studies reporting approximately 18,000 patients with borderline ovarian tumors were reviewed. After excluding series that lacked clinical follow-up or were not analyzable for other reasons, there remained 97 reports that included 4,129 patients. In addition to recurrences and survival, we evaluated the type of peritoneal implants, microinvasion, lymph node involvement, late recurrences, and progression to carcinoma, as these features have served as the underpinning of the concept of "borderline malignancy" or "low malignant potential." RESULTS: Among 4,129 patients with SBTs reviewed, the recurrence rate after a mean follow-up of 6.7 years was 0.27% per year for stage I tumors, the disease-free survival was 98.2%, and the overall disease-specific survival rate was 99.5%. For patients with advanced-stage tumors, the recurrence rate was 2.4% per year. However, the majority (69%) of reported recurrences were not pathologically documented, and only 26 cases (8.4% of all recurrences) were documented to have recurred from an adequately sampled ovarian tumor. The most reliable prognostic indicator for advanced stage tumors was the type of peritoneal implant. After 7.4 years of follow-up, the survival of patients with noninvasive peritoneal inplants was 95.3%, as compared with 66% for invasive implants (P < .0001). Microinvasion in the primary ovarian tumor was associated with a 100% survival rate at 6.7 years, and lymph node involvement was associated with a 98% survival rate at 6.5 years. The few reported cases of stage IV disease, progression to invasive carcinoma, and very late (>20 years) recurrences were poorly documented. The survival for all stages among approximately 373 patients in 6 prospective randomized trials followed for a mean of 6.7 years was 100%. CONCLUSION: Surgical pathological stage and subclassification of extraovarian disease into invasive and noninvasive implants are the most important prognostic indicators for SBTs. Survival for stage I tumors is virtually 100%. Survival for advanced stage tumors with noninvasive implants is 95.3%, whereas survival for tumors with invasive implants is 66%. Invasive implants behave as carcinomas and are most likely metastatic. The precise nature of so-called noninvasive implants is not clear, but they behave in a benign fashion. The presence of a micropapillary architecture in the primary ovarian tumor is a strong predictor of invasive implants. These data support the recommendation that ovarian tumors with a micropapillary architecture be designated "micropapillary serous carcinomas," and those lacking these features, "atypical proliferative serous tumors."
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rubin, M., & Stephen, C. D. (1993) · Cited by 3,149
Firminger, H. I. (1968) · Armed Forces Institute of Pathology eBooks · Cited by 3,044
Meta-Analysis in Clinical Research
L'ABBÉ, K. A., DETSKY, A. S., & O'ROURKE, K. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-224 · Cited by 1,267
The Medical Review Article: State of the Science
MULROW, C. D. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-3-485 · Cited by 856
(2012) · Elsevier eBooks · doi:10.1016/c2009-0-43803-0 · Cited by 757
Histological Typing of Ovarian Tumours
Scully, R. E. (1999) · Springer eBooks · doi:10.1007/978-3-642-58564-7 · Cited by 654
Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament
Scully, R. E., Young, R. H., & Clement, P. B. (1999) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199907000-00019 · Cited by 617
Young, R. C., Walton, L. A., Ellenberg, S. S., Homesley, H. D., Wilbanks, G. D., Decker, D. G., Miller, A., Park, R., & Major, F. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004123221501 · Cited by 583
Whittemore, A. S., Harris, R., Itnyre, J., Halpern, J., & the Collaborative Ovarian Cancer Group (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116426 · Cited by 525
Guidelines for reading literature reviews.
Oxman, A. D., & Guyatt, G. H. (1988) · Europe PMC (PubMed Central) · Cited by 489
Fox, H. (1980) · Journal of Clinical Pathology · doi:10.1136/jcp.33.10.1016-d · Cited by 438
Blaustein’s Pathology of the Female Genital Tract
Warren, B. (1995) · Pathology · doi:10.1016/s0031-3025(16)35342-9 · Cited by 409
Tumors of the ovary and maldeveloped gonads
Scully, R. E. (1979) · Armed Forces Institute of Pathology eBooks · Cited by 407
Adnexal masses in pregnancy: A review of 130 cases undergoing surgical management
Whitecar, P., Turner, S., & Higby, K. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70429-1 · Cited by 365
[Prognostic factors in patients with stage I epithelial ovarian cancer].
Wen, H. W., & Liu, S. W. (1994) · PubMed · Cited by 353
Burks, R. T., Sherman, M. E., & Kurman, R. J. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199611000-00003 · Cited by 314
Self-citationBerek, J. S. (1996) · Medical Entomology and Zoology · Cited by 301
Systematic Reviews: Meta-analysis and its problems
Eysenck, H. J. (1994) · BMJ · doi:10.1136/bmj.309.6957.789 · Cited by 293
Prognostic factors in patients with stage I epithelial ovarian cancer.
Dembo, A. J., Davy, M., Stenwig, A. E., et al. (1990) · PubMed · Cited by 291
Seidman, J. D., & Kurman, R. J. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199611000-00004 · Cited by 290
Self-citationClassification and Staging of Malignant Tumours in the Female Pelvis
(1971) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.3109/00016347109157278 · Cited by 285
Gospodarowicz, M., & O'Sullivan, B. (2003) · Seminars in Surgical Oncology · doi:10.1002/ssu.10016 · Cited by 283
Harris, R., Whittemore, A. S., & Itnyre, J. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116428 · Cited by 275
Studies on Bilirubin in Amniotic Fluid: With Special Reference to Liver Function Tests
Ojala, A. (1971) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.3109/00016347109157182 · Cited by 271
Risch, H. A., Marrett, L. D., Jain, M., & Howe, G. R. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008937 · Cited by 257
Clinical and histologic studies of ovarian carcinoma. Long-term follow-up of 990 cases.
Aure, J. C., Høeg, K., & Kolstad, P. (1971) · PubMed · Cited by 253
Blausteinʼs Pathology of the Female Genital Tract
&NA; (1988) · International Journal of Gynecological Pathology · doi:10.1097/00004347-198809000-00010 · Cited by 253
Scully, R. E. (1977) · PubMed · Cited by 244
Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.
Mok, S. C., Bell, D. A., KNAPP, R. C., Fishbaugh, P. M., Welch, W. R., Muto, M. G., Berkowitz, R. S., & Tsao, S. (1993) · PubMed · Cited by 237
Meta-analysis. A quantitative approach to research integration
Thacker, S. B. (1988) · JAMA · doi:10.1001/jama.259.11.1685 · Cited by 237
p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
Teneriello, M. G., Ebina, M., Linnoila, R. I., Henry, M., Nash, J. D., Park, R. C., & Birrer, M. J. (1993) · PubMed · Cited by 211
A case-control study of epithelial ovarian cancer
Hartge, P., Schiffman, M. H., Hoover, R., McGowan, L., Lesher, L., & Norris, H. J. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90221-4 · Cited by 206
Common Epithelial Cancer of the Ovary
Richardson, G. S., Scully, R. E., Nikrui, N., & Nelson, J. H. (1985) · New England Journal of Medicine · doi:10.1056/nejm198502143120706 · Cited by 204
Eichhorn, J. H., Bell, D. A., Young, R. H., & Scully, R. E. (1999) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199904000-00004 · Cited by 204
Ovarian serous borderline tumors with invasive peritoneal implants
Gershenson, D. M., Silva, E. G., Levy, L., Burke, T. W., Wolf, J. K., & Tornos, C. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980315)82:6<1096::aid-cncr13>3.0.co;2-1 · Cited by 203
Prognostic factors in ovarian cancer.
Friedlander, M. L., & Dembo, A. J. (1991) · PubMed · Cited by 186
Kennedy, A. W., & Hart, W. R. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960715)78:2<278::aid-cncr14>3.0.co;2-t · Cited by 175
Serous borderline tumors of the ovary with noninvasive peritoneal implants
Gershenson, D. M., Silva, E. G., Tortolero-Luna, G., Levenback, C., Morris, M., & Tornos, C. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981115)83:10<2157::aid-cncr14>3.0.co;2-d · Cited by 173
Bergman, F. (1966) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.3109/00016346609158447 · Cited by 170
Borderline tumors of the ovary: Fertility treatment, conservative management, and pregnancy outcome
Gotlieb, W. H., Flikker, S., Davidson, B., Korach, Y., Kopolovic, J., & Ben-Baruch, G. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980101)82:1<141::aid-cncr17>3.0.co;2-2 · Cited by 170
Serous Borderline Tumors of the Peritoneum
Bell, D. A., & Scully, R. E. (1990) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199003000-00004 · Cited by 168
Kærn, J., Tropé, C. G., & Abeler, V. M. (1993) · Cancer · doi:10.1002/1097-0142(19930301)71:5<1810::aid-cncr2820710516>3.0.co;2-v · Cited by 166
Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma
Puls, L. E., Powell, D. E., DePriest, P. D., Gallion, H. H., Hunter, J. E., Kryscio, R. J., & Van Nagell, J. R. (1992) · Gynecologic Oncology · doi:10.1016/0090-8258(92)90075-t · Cited by 163
Surface Epithelial—Stromal Tumors of the Ovary
Russell, P. (1994) · Blaustein’s Pathology of the Female Genital Tract · doi:10.1007/978-1-4757-3889-6_18 · Cited by 161
The Behavior of Serous Tumors of Low Malignant Potential
Kurman, R. J., & Trimble, C. L. (1993) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199304000-00006 · Cited by 161
Self-citationBarnhill, D. R., Kurman, R. J., Brady, M. F., Omura, G. A., Yordan, E., Given, F. T., Kucera, P. R., & Roman, L. D. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.11.2752 · Cited by 159
Self-citationTimmerman, D., Bourne, T. H., Tailor, A., Collins, W. P., Verrelst, H., Vandenberghe, K., & Vergote, I. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70436-9 · Cited by 159
Daraï, É., Scoazec, J., Walker, F., Mlika-Cabanne, N., Feldmann, G., Madélénat, P., & Potet, F. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90007-1 · Cited by 146
Leeds, M. (1977) · PubMed · Cited by 140
Serous ovarian tumors of low malignant potential with peritoneal implants
Gershenson, D. M., & Silva, E. G. (1990) · Cancer · Cited by 138
Morphologic precursors of ovarian epithelial tumors.
Resta, L., Russo, S., Colucci, G. A., & Prat, J. (1993) · PubMed · Cited by 133
Friedlander, M. L., Hedley, D. W., Swanson, C. E., & Russell, P. J. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.2.282 · Cited by 127
Epithelial ovarian carcinoma in the reproductive age group
Duska, L., Chang, Y., Flynn, C. E., Chen, A. H., Goodman, A., Fuller, A. F., & Nikrui, N. (1999) · Cancer · Cited by 121
Contralateral Ovary in Unilateral Ovarian Carcinoma
Mittal, K., Zeleniuch‐Jacquotte, A., Cooper, J. L., & Demopoulos, R. I. (1993) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199301000-00008 · Cited by 116
Pathology in Gynecology and Obstetrics,
Compel, C., Silverberg, S. G., & Kraus, F. T. (1995) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199512000-00017 · Cited by 111
Allelic deletion on chromosome 17p13.3 in early ovarian cancer.
Phillips, N. J., Ziegler, M. R., Radford, D. M., Fair, K., Steinbrueck, T., Xynos, F. P., & Donis-Keller, H. (1996) · PubMed · Cited by 110
Importance of histologic grading in the prognosis of epithelial ovarian carcinoma.
Sorbe, B., Frankendal, B., & VERESS, B. (1982) · PubMed · Cited by 106
The pathological assessment of ovarian neoplasms. II: The proliferating ‘epithelial’ tumours
Russell, P. J. (1979) · Pathology · doi:10.3109/00313027909061951 · Cited by 102
Caduff, R. F., Svoboda-Newman, S. M., Ferguson, A. W., Johnston, C. M., & Frank, T. S. (1999) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199903000-00012 · Cited by 102
Histologic typing of ovarian tumors.
Scully, R. E., & Sobin, L. H. (1987) · PubMed · Cited by 102
Ferguson, B., Bennington, J. L., & Haber, S. (1969) · PubMed · Cited by 100
Peritoneal epithelial lesions associated with proliferative serous tumours of ovary
McCaughey, W., Kirk, M. E., Lester, W. M., & Dardick, I. (1984) · Histopathology · doi:10.1111/j.1365-2559.1984.tb02336.x · Cited by 99
Harlow, B. L., Weiss, N. S., Roth, G. J., Chu, J. Y., & Daling, J. R. (1988) · PubMed · Cited by 98
Garzetti, G. G., Ciavattini, A., Goteri, G., et al. (1995) · Gynecologic Oncology · doi:10.1006/gyno.1995.1026 · Cited by 95
Afzal, S., Lalani, E., Poulsom, R., Stubbs, A., Rowlinson, G., Sato, H., Seiki, M., & Stamp, G. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90226-x · Cited by 90
Ovarian surface epithelial-stromal tumors
Bell, D. A. (1991) · Human Pathology · doi:10.1016/0046-8177(91)90205-4 · Cited by 89
Prognostic factors in ovarian cancer
Trope, C. G. (1998) · Cancer treatment and research · doi:10.1007/978-1-4615-5447-9_11 · Cited by 86
Ovarian stimulation and borderline ovarian tumors: a case-control study
Mosgaard, B. J., Lidegaard, Ø., Kjær, S. K., Schou, G., & Andersen, A. N. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00337-9 · Cited by 82
Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors.
Lu, K. H., Bell, D. A., Welch, W. R., Berkowitz, R. S., & Mok, S. C. (1998) · PubMed · Cited by 79
Zheng, J., Benedict, W. F., Xu, H., Hu, S., Kim, T. M., Velicescu, M., Wan, M., Cofer, K. F., & Dubeau, L. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.15.1146 · Cited by 75
Cuatrecasas, M., Erill, N., Musulén, E., et al. (1998) · PubMed · Cited by 72
The National Cancer Data Base report on ovarian cancer treatment in United States hospitals
Partridge, E. E., Phillips, J. L., & Menck, H. R. (1996) · Cancer · Cited by 72
Berchuck, A., Kohler, M. F., Hopkins, M. P., Humphrey, P. A., Robboy, S. J., Rodriguez, G. C., Soper, J. T., Clarke‐Pearson, D. L., & Bast, R. C. (1994) · Gynecologic Oncology · doi:10.1006/gyno.1994.1037 · Cited by 69
Epithelial ovarian cancer in the elderly: The memorial sloan-kettering cancer center experience
Markman, M. M., Lewis, J. L., Saigo, P. E., Hakes, T., Jones, W. B., Rubin, S. C., Reichman, B. S., Barakat, R. R., Curtin, J. P., Almadrones, L., et al. (2010) · Cancer · doi:10.1002/cncr.2820710222 · Cited by 67
The Concurrent Expression of p27kip1and Cyclin D1 in Epithelial Ovarian Tumors
Sui, L., Tokuda, M., Ohno, M., Hatase, O., & Hando, T. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5373 · Cited by 67
p53 gene analysis of ovarian borderline tumors and stage I carcinomas*1
Kupryjańczyk, J. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90138-8 · Cited by 66
Nictolis, M. D., Montironi, R., Tommasoni, S., Carinelli, S. G., Ojeda, B., Matías‐Guiu, X., & Prat, J. (1992) · Cancer · Cited by 65
Clinical significance of abnormal nuclear DNA content in serous ovarian tumors
Klemi, P. J., Joensuu, H., Kiilholma, P., & Mäenpää, J. (1988) · Cancer · doi:10.1002/1097-0142(19881101)62:9<2005::aid-cncr2820620922>3.0.co;2-q · Cited by 65
p53 Gene Mutation in Human Borderline Epithelial Ovarian Tumors
Wertheim, I., Muto, M. G., Welch, W. R., Bell, D. A., Berkowitz, R. S., & Mok, S. C. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.20.1549 · Cited by 63
Common Epithelial Tumors of the Ovary
Czernobilsky, B. (1987) · Springer eBooks · doi:10.1007/978-1-4757-1942-0_18 · Cited by 59
Saretzki, G. C., Hoffmann, U., R�hlke, P., Psille, R., Gaigal, T., Keller, G., H�fler, H., L�ning, T., Petersen, I., & Dietel, M. (1997) · Cancer · Cited by 56
The Classification and Treatment of Ovarian Tumours
Kottmeier, H. ‐. (1952) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016345209154959 · Cited by 55
Björkholm, E., Pettersson, F., Einhorn, N., Krebs, I., Nilsson, B. R., & Tjernberg, B. (1982) · Acta Radiologica Oncology · doi:10.3109/02841868209134321 · Cited by 55
Oberman, H. A. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199607000-00022 · Cited by 54
The prognostic variability of ovarian tumor grading by different pathologists
Baak, J. P. A., Langley, F. A., Talerman, A., et al. (1987) · Gynecologic Oncology · doi:10.1016/0090-8258(87)90289-7 · Cited by 53
A CASE-CONTROL STUDY OF BORDERLINE OVARIAN TUMORS: THE INFLUENCE OF PERINEAL EXPOSURE TO TALC
Harlow, B. L., & Weiss, N. S. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115345 · Cited by 48
Osteopontin expression in ovarian carcinomas and tumors of low malignant potential (LMP)
TINIAKOS, D. G., Yu, H., & Liapis, H. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90253-2 · Cited by 46
Borderline Ovarian Tumors in Finland: Epidemiology and Familial Occurrence
Auranen, A., Grénman, S., Mäkinen, J., Pukkala, ., Sankila, R. J., & Salmi, T. T. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008964 · Cited by 46
Zheng, J., Wan, M., Zweizig, S., Velicescu, M., Yu, M. C., & Dubeau, L. (1993) · PubMed · Cited by 46
Benign, Borderline and Malignant Serous Cystadenomas of the Ovary
Stenbäck, F. (1981) · Pathology - Research and Practice · doi:10.1016/s0344-0338(81)80123-9 · Cited by 37
Risk Factors for Epithelial Ovarian Tumours of Borderline Malignancy
Parazzini, F., Restelli, C., Vecchia, C. L., et al. (1991) · International Journal of Epidemiology · doi:10.1093/ije/20.4.871 · Cited by 36
Wolf, N. G., Abdul‐Karim, F. W., Schork, N. J., & Schwartz, S. (1996) · Europe PMC (PubMed Central) · Cited by 33
Surface (germinal) epithelium and related ovarian neoplasms.
Blaustein, A. (1981) · PubMed · Cited by 33
p53 and HER-2/neu Overexpression in Ovarian Borderline Tumors
Eltabbakh, G. H., Belinson, J. L., KENNEDY, A. W., Biscotti, C. V., Casey, G., & Tubbs, R. R. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1997.4661 · Cited by 32
Pathology in Gynecology and Obstetrics
Crawford, R. M. C. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.1.94-a · Cited by 29
Shih, Y.-C., Kerr, J., Hurst, T., Khoo, S., Ward, B. G., & Chenevix‐Trench, G. (1998) · Gynecologic Oncology · doi:10.1006/gyno.1998.5014 · Cited by 28
Hypermethylation at a chromosome 17 ?Hot spot? is a common event in ovarian cancer*1
Pieretti, M. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90140-x · Cited by 28
Systematic reviews of medical evidence: The use of meta-analysis in obstetrics and gynecology
Peipert, J. F., & Bracken, M. B. (1997) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(96)00490-5 · Cited by 25
Investigation of ovarian neoplasia of low malignant potential for human papillomavirus
McLellan, R. K., Buscema, J., Guerrero, E., Shah, K. V., Woodruff, J. D., & Currie, J. L. (1990) · Gynecologic Oncology · doi:10.1016/0090-8258(90)90078-y · Cited by 24
Metaanalysis for the obstetrician-gynecologist
Thacker, S. B., Peterson, H. B., & Stroup, D. F. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70580-x · Cited by 22
REFLECTIONS UPON REFORM IN MEDICAL EDUCATION
Lewis, T. A. (1944) · The Lancet · doi:10.1016/s0140-6736(00)74840-9 · Cited by 22
Crickard, K., Marinello, M. J., Crickard, U., Satchidanand, S. K., Yoonessi, M., & Caglar, H. (1986) · PubMed · Cited by 22
The characteristics of ovarian serous tumors of borderline malignancy.
My, T., Lj, L., & Th, L. (1980) · PubMed · Cited by 15
Zanotti, K. M., Hart, W. R., KENNEDY, A. W., Belinson, J. L., & Casey, G. (1999) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199907000-00010 · Cited by 14
Simpson, W. M. (1947) · American Journal of Clinical Pathology · doi:10.1093/ajcp/17.7.513 · Cited by 14
Ovarian tumors of borderline malignancy
Schlosshauer, P. W. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003254.006 · Cited by 11
The incidence of borderline ovarian tumors in israel: A population-based study
Iscovich, J., Shushan, A., Schenker, J. G., & Paltiel, O. (1998) · Cancer · Cited by 11
Dietel, M. (1983) · PubMed · Cited by 10
Cited by
Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma
Singer, G., Oldt, R., Cohen, Y., Wang, B. G., Sidransky, D., Kurman, R. J., & Shih, I.-M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.484 · Cited by 854
Self-citationKurman, R. J., & Shih, I.-M. (2008) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e318161e4f5 · Cited by 460
Self-citationSinger, G., Stöhr, R., Cope, L., Dehari, R., Hartmann, A., Cao, D.-F., Wang, T.-L., Kurman, R. J., & Shih, I.-M. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000146025.91953.8d · Cited by 408
Self-citationLevine, D., Brown, D. L., Andreotti, R. F., Benacerraf, B., Benson, C. B., Brewster, W. R., Coleman, B., DePriest, P., Doubilet, P. M., Goldstein, S. R., et al. (2010) · Radiology · doi:10.1148/radiol.10100213 · Cited by 360
Longacre, T. A., McKenney, J. K., Tazelaar, H. D., Kempson, R. L., & Hendrickson, M. R. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000164030.82810.db · Cited by 323
Metadata
- Authors
- Seidman, J. D., & Kurman, R. J.
- Venue
- Human Pathology
- Publisher
- Elsevier BV
- Published
- 2000-05
- Volume
- 31
- Issue
- 5
- Pages
- 539-557
- ISSN
- 0046-8177 (ISSN-L)
- OpenAlex
- W2149122549
- Cited by
- 410
- References
- 108
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.